Search research articles
Contact Us
Filters
Showing results (1-10 of 241) with videos related to
Page
of 25
Sort By:
The Review of Regional Studies
|
January 1, 1988
Prior geographic mobility and job search length
E Goss
American Journal of Clinical Oncology
|
August 7, 2003
Emerging role of aromatase inhibitors in the adjuvant setting
Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2002
Preliminary data from ongoing adjuvant aromatase inhibitor trials
P E Goss
Seminars in Oncology
|
February 22, 2005
Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancer
Paul E Goss
Seminars in Oncology
|
May 30, 2006
Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial
Paul E Goss
Leukemia & Lymphoma
|
June 1, 1993
Non-Hodgkin's lymphomas in elderly patients
P E Goss
Anti-Cancer Drugs
|
June 24, 2008
Addressing the future: combination with targeted therapies, adjuvant setting and beyond
Paul E Goss
The Journal of Steroid Biochemistry and Molecular Biology
|
November 19, 2003
Breast cancer prevention--clinical trials strategies involving aromatase inhibitors
Paul E Goss
Endocrine-Related Cancer
|
March 24, 2000
Risks versus benefits in the clinical application of aromatase inhibitors
P E Goss
Breast Cancer Research and Treatment
|
September 12, 2008
Extending the benefits of adjuvant therapy in early HR+ breast cancer
Paul E Goss
Page
of 25
Search research articles
Search
Showing results (1-10 of 241) with videos related to
Sort By:
Page
of 25
The Review of Regional Studies
|
January 1, 1988
Prior geographic mobility and job search length
E Goss
American Journal of Clinical Oncology
|
August 7, 2003
Emerging role of aromatase inhibitors in the adjuvant setting
Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2002
Preliminary data from ongoing adjuvant aromatase inhibitor trials
P E Goss
Seminars in Oncology
|
February 22, 2005
Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancer
Paul E Goss
Seminars in Oncology
|
May 30, 2006
Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial
Paul E Goss
Leukemia & Lymphoma
|
June 1, 1993
Non-Hodgkin's lymphomas in elderly patients
P E Goss
Anti-Cancer Drugs
|
June 24, 2008
Addressing the future: combination with targeted therapies, adjuvant setting and beyond
Paul E Goss
The Journal of Steroid Biochemistry and Molecular Biology
|
November 19, 2003
Breast cancer prevention--clinical trials strategies involving aromatase inhibitors
Paul E Goss
Endocrine-Related Cancer
|
March 24, 2000
Risks versus benefits in the clinical application of aromatase inhibitors
P E Goss
Breast Cancer Research and Treatment
|
September 12, 2008
Extending the benefits of adjuvant therapy in early HR+ breast cancer
Paul E Goss
Page
of 25